9th Annual Biomarkers Congress

Antibodies: Food and Drug Administration

Total Score People Score Events Score
8 8 4
Date Event Presentation Speakers
May 20, 2010 Antibody Optimization Trastuzumab Conjugate for the Treatment of Trastuzumab-Resistant Human Breast Cancer: Increasing Magnitude and Duration of Response Wen Jin Wu
May 4, 2010 Biomarker World Congress 2010 Biomarkers and the Development of Personalized Medicine: A Regulatory Perspective Francis Kalush
Role of Biomarkers in Drug Development: Application in Late Phase Clinical Trials Yaning Wang
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Regulatory Approaches for Safety Assessment of Drug Metabolites Aisar Atrakchi
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Regulatory Perspectives (13:25-17:00) Emily Shacter, Malcolm Moos, Kathleen A. Clouse
Regulatory Perspectives: Assessing Impurities in Biotherapeutics (16:00-16:30) Kathleen A. Clouse
Regulatory Perspectives: Potency Issues - Cell-Based Functional Assays vs. Binding Assays (14:30-15:00) Emily Shacter
Regulatory Perspectives: Problems and Limitations with Analytical Methods - A Regulator's Perspective (15:30-16:00) Malcolm Moos
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) Ingrid Markovic
Impact of Extractables and Leachables on Well Characterized Protein Products: Regulatory Considerations for Evaluating the Impact of Extractables and Leachables - A Risk-Based Approach (10:45-11:15) Ingrid Markovic
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.